(Q44438732)

English

Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus

scientific article published in January 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Newcastle disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Newcastle disease virus

object named as

Newcastle disease virus

1 reference

based on heuristic

inferred from title

author name string

Schirrmacher V

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Haas C

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Bonifer R

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Ahlert T

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Gerhards R

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Ertel C

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

63-73

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3300787

0 references

Newcastle disease virus pathotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

NEWCASTLE DISEASE VIRUS AS AN ANTINEOPLASTIC AGENT.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon Production in Mouse Spleen Cells and Mouse Fibroblasts (L Cells) Stimulated by Various Strains of Newcastle Disease Virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-alpha and augmentation of its cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Newcastle disease virus selectively kills human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of cytokines and cytotoxicity against tumor cells by Newcastle disease virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Virus Augmentation of The Antigenicity of Tumor Cell

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study on the postsurgical management of Stage II malignant melanoma with a Newcastle disease virus oncolysate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and clinical characterisation of a newcastle disease virus-modified autologous tumour cell vaccine for treatment of colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral Xenogenization of Intact Tumor Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Active specific immunotherapy of established micrometastasis: effect of cryopreservation procedures on tumor cell immunogenicity in guinea pigs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice.: Iv. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunityin vivo and of cytolytic T cellsin vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. II. Establishment of specific systemic anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutational changes of the protease susceptibility of glycoprotein F of Newcastle disease virus: effects on pathogenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Modification of tumor cells by a low dose of Newcastle disease virus. Augmentation of the tumor-specific T cell response in the absence of an anti-viral response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Modification of tumor cells by a low dose of Newcastle disease virus. III. Potentiation of tumor-specific cytolytic T cell activity via induction of interferon-alpha/beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral hemagglutinin augments peptide-specific cytotoxic T cell responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Postoperative active specific immunization in colorectal cancer patients with virus-modified autologous tumor-cell vaccine. First clinical results with tumor-cell vaccines modified with live but avirulent Newcastle disease virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of murine RANTES chemokine gene induction by Newcastle disease virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Active specific immunotherapy with Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant treatment of locally advanced renal cancer with autologous virus-modified tumor vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

THE AGGLUTINATION OF RED CELLS BY ALLANTOIC FLUID OF CHICK EMBRYOS INFECTED WITH INFLUENZA VIRUS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibodies to hemagglutinin-neuraminidase and fusion glycoproteins of Newcastle disease virus: relationship between glycosylation and reactivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300787

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3300787

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44438732&oldid=2023603362"